首页 | 本学科首页   官方微博 | 高级检索  
     


Aspirin,ibuprofen, and reduced risk of advanced colorectal adenoma incidence and recurrence and colorectal cancer in the PLCO Cancer Screening Trial
Authors:Kenechukwu Chudy-Onwugaje MBBS  MPH   MS  Wen-Yi Huang PhD  MSPH  L. Joseph Su PhD  MPH  Mark P. Purdue PhD  Christine C. Johnson PhD  Lingxiao Wang PhD  Hormuzd A. Katki PhD  Kathryn Hughes Barry PhD  MPH  Sonja I. Berndt PharmD  PhD
Affiliation:1. Division of Gastroenterology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania;2. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland;3. Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, Arkansas;4. Department of Public Health Sciences, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan;5. Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland

Program in Oncology, University of Maryland Marlene and Stewart Greenbaum Comprehensive Cancer Center, Baltimore, Maryland

Abstract:
Keywords:aspirin  colorectal cancer  ibuprofen  incident adenoma  recurrent adenoma
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号